<?xml version="1.0" encoding="UTF-8"?>
<p>Another research group [
 <xref rid="B107-ijms-21-07078" ref-type="bibr">107</xref>] tested the in vitro effects of (1
 <italic>S</italic>,2
 <italic>R</italic>,4
 <italic>S</italic>)-1,7,7-trimethyl-bicyclo[2.2.1]heptan-2-yl-3′,4′,5′-trimethoxy benzoate 
 <bold>130c</bold> and (1
 <italic>S</italic>,2
 <italic>R</italic>,4
 <italic>S</italic>)-1,7,7-trimethyl-bicyclo[2.2.1]heptan-2-yl benzoate 
 <bold>130d</bold> on the growth and ultrastructure of 
 <italic>Trypanosoma cruzi</italic>. These two (–)-borneol ester derivatives exerted an antiproliferative effect on the epimastigote forms of the parasite and might be used as a potential source for the development of more effective and safer chemotherapeutic agents against 
 <italic>T. cruzi</italic> infections.
</p>
